Tue, Jul 29, 2014, 5:52 AM EDT - U.S. Markets open in 3 hrs 38 mins

Recent

% | $
Click the to save as a favorite.

Questcor Pharmaceuticals, Inc. (QCOR) Message Board

  • jkistotass jkistotass Mar 22, 2013 11:31 AM Flag

    so who is this lafferty guy anyways?

    So who is this guy? I guess Mikey won't post info, but does anybody have anything substantive on these comments? I've viewed every pullback as an opportunity and so far it's worked out. I want to add again, but I can't find any info on this dude. TIA.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • It's R.F. Lafferty and this is what they do. Release bogus information to ensure volatility.

      Cathy Reese, MD and Bob Chaiken (her boss) haven't released one accurate research report that I've seen on QCOR. They are the brain childs that thought Synacthen was approved, instead of a weekend worth of paperwork for a 'designation' that the FDA teaches normal folks to be able to do in classes they conduct.

      Now, given their credentials, they are either stupid and paid someone to give them passing marks in school... Or they know they give out misinformation to ensure this volatility.

      It's easy in biotech, since even investment fund managers don't understand drugs. Just like Cramer and Adam F... say whatever you want for the stock to go a certain way, cuz no one of any authority will know better.

    • All the arguments against QCOR is basically similar because layman's understanding of the medical use and advantage of ACTHAR is not well understood and appreciated unless you're the a patient who needs it. But year after year, the continued use is well documented and revenues are increasing every year. What else is there to say but to take advantage of this price manipulations and profit from it.

      Sentiment: Strong Buy

    • Edward A. Lafferty
      bald guy working for saturn partners
      search google

 
QCOR
93.67-1.23(-1.30%)Jul 28 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.